全文获取类型
收费全文 | 3128篇 |
免费 | 216篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 104篇 |
妇产科学 | 65篇 |
基础医学 | 353篇 |
口腔科学 | 53篇 |
临床医学 | 310篇 |
内科学 | 781篇 |
皮肤病学 | 71篇 |
神经病学 | 165篇 |
特种医学 | 106篇 |
外科学 | 555篇 |
综合类 | 98篇 |
一般理论 | 1篇 |
预防医学 | 183篇 |
眼科学 | 57篇 |
药学 | 220篇 |
中国医学 | 12篇 |
肿瘤学 | 182篇 |
出版年
2022年 | 23篇 |
2021年 | 62篇 |
2020年 | 28篇 |
2019年 | 58篇 |
2018年 | 51篇 |
2017年 | 46篇 |
2016年 | 55篇 |
2015年 | 66篇 |
2014年 | 69篇 |
2013年 | 111篇 |
2012年 | 156篇 |
2011年 | 188篇 |
2010年 | 86篇 |
2009年 | 96篇 |
2008年 | 116篇 |
2007年 | 132篇 |
2006年 | 135篇 |
2005年 | 123篇 |
2004年 | 122篇 |
2003年 | 91篇 |
2002年 | 79篇 |
2001年 | 60篇 |
2000年 | 83篇 |
1999年 | 55篇 |
1998年 | 33篇 |
1997年 | 28篇 |
1995年 | 21篇 |
1992年 | 84篇 |
1991年 | 45篇 |
1990年 | 55篇 |
1989年 | 50篇 |
1988年 | 51篇 |
1987年 | 54篇 |
1986年 | 45篇 |
1985年 | 45篇 |
1984年 | 28篇 |
1983年 | 22篇 |
1980年 | 20篇 |
1979年 | 45篇 |
1978年 | 33篇 |
1977年 | 34篇 |
1976年 | 21篇 |
1975年 | 30篇 |
1974年 | 30篇 |
1973年 | 49篇 |
1972年 | 36篇 |
1971年 | 25篇 |
1970年 | 22篇 |
1969年 | 25篇 |
1968年 | 20篇 |
排序方式: 共有3348条查询结果,搜索用时 5 毫秒
41.
Gro Tunheim Gunnar
yvind Isaksson R Adity Chopra Audun Aase AnneMarte Bakken Kran John Torgils Vaage Fridtjof LundJohansen Olav Hungnes 《Influenza and other respiratory viruses》2022,16(6):1004
BackgroundOne year into the COVID‐19 pandemic, the cumulative number of confirmed COVID‐19 cases in Norway was still low. In January 2021, when the Norwegian COVID‐19 vaccination campaign started, the national seroprevalence estimate of SARS‐CoV‐2 antibodies was 3.2%. We have conducted a nationwide cross‐sectional study in August 2021 to investigate the overall prevalence of SARS‐CoV‐2 antibodies in Norway after 8 months of COVID‐19 mass vaccination and a third wave of SARS‐CoV‐2 infection.MethodsResidual sera were collected from laboratories across Norway in August 2021. In IgG antibodies against the spike protein, the spike receptor binding domain (RBD) and the nucleocapsid protein of SARS‐CoV‐2 were measured by a bead‐based flow cytometric assay.ResultsIn total, 1926 residual sera were collected from individuals aged 0–98 years; 55.1% were from women. The overall national estimated seroprevalence from vaccination and/or infection was 62.6% (credible interval [CrI] 60.1%–65.2%) based on having antibodies against both spike and RBD. Estimated seroprevalence increased with age. Among all samples, 11.7% had antibodies against nucleocapsid. For unvaccinated children <12 years, the seroprevalence estimate due to SARS‐CoV‐2 infection was 12.5% (95% CrI 9.3%–16.1%). Of seropositive samples from the unvaccinated children, 31.9% lacked anti‐nucleocapsid antibodies.ConclusionsThe high overall SARS‐CoV‐2 seroprevalence estimates are in line with Norwegian registry data. Vaccination, not infection, contributed the most to the high seroprevalence in August 2021. Lack of antibodies against nucleocapsid should not automatically be interpreted as absence of previous infection as this could lead to underestimation of COVID‐19 cases in seroprevalence studies. 相似文献
42.
43.
44.
45.
46.
47.
48.
49.
Monika Chopra H. S. Rehan Rachna Gupta F. J. Ahmad M. D. Tariq L. K. Gupta 《Indian journal of pharmaceutical sciences》2014,76(5):462-465
For the prevention of postoperative ocular infections prophylactic topical antibiotics are routinely used. Studies evaluating comparative difference between single dose versus multiple dose administration on aqueous humour concentration of moxifloxacin are lacking. This study compared the aqueous humour concentration of moxifloxacin following its topical administration in rabbit eyes with two dose regimens. Twelve albino rabbits were divided into two groups. In group-1, two drops were administered thrice (total six drops) at 2 min intervals, in both the eyes; in group-2, two drops of moxifloxacin were administered three times a day for three days and also two h before aqueous humour collection i.e. on fourth day. Mean aqueous humour concentrations were calculated and compared using Student''s ‘t’ test and P<0.05 was considered significant. Moxifloxacin concentration in aqueous humour in group-1 was 23.79 μg/ml and in group-2 was 42.08 μg/ml. Both dosing regimens produced substantially higher aqueous concentrations than the known minimum inhibitory concentration for most bacteria. Moxifloxacin concentration in aqueous humour with multiple instillations is significantly higher than single instillation (P<0.05), which is adequate to cover ciprofloxacin-resistant gram-negative bacteria. Repeated topical moxifloxacin administration achieved significantly higher aqueous humour concentrations than single administration. 相似文献
50.